Abstract:Background: Due to the limits of effective treatments, avian influenza A H5N1 virus is the most lethal influenza virus strain that causes severe acute lung injury (ALI). To develop effective drugs ameliorating H5N1-induced ALI, we explore an RNA interference (RNAi) screening method to monitor changes in cell death induced by H5N1 infection. According to the estimation of the Bernard Munos, a drug-development advocacy organization in Washington DC, "the proportion of drugs that in theory could be repositioned is probably approximately 75%."Methods: We screened 19,424 RNAi in A549 lung epithelial cells and examined cell death induced by H5N1 infection. These screenings identified 1137 host genes for which knockdown altered cell viability by over 20%. DrugBank searches of these 1137 host genes identified 146 validated druggable target genes with 372 drug candidates. We obtained 104 commercially available drugs with 65 validated target genes and examined their improvements in cell viability following H5N1 infection. We identified 28 drugs that could significantly recover cell viability following H5N1 infection and tested 10 in an H5N1-induced ALI mouse model.Findings: The neurological drug ifenprodil and the anticancer drug flavopiridol markedly decreased infiltrated leukocytes and lung injury scores in infected mouse lungs and significantly ameliorated lung edema in infected mouse lung tissue.Interpretation: Ifenprodil is an antagonist of the N-methyl-D-aspartate (NMDA) receptor, which is linked to inflammation and lung injury. Flavopiridol is an inhibitor of CDK4, which is linked to leukocyte migration and lung injury. These results suggest that ifenprodil and flavopiridol are novel remedies against potential H5N1 epidemics in addition to their proven indications. Furthermore, our strategy for identifying repurposable drugs could serve as a general approach for other diseases.Funding Statement: This work was supported by the National Natural Science Foundation of China (81788101, 81490531), the Ministry of Science and Technology of China (2015CB553406) and the CAMS Innovation Fund for Medical Sciences (2017-I2M-1-009).Declaration of Interests: The authors declare that they have no competing interests.Ethics Approval Statement: Animal experiments in this work were approved by the Ethics Committee of the Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences (ACUC-A02-2017-014).

Andrographolide as an Anti-H1N1 drug and the mechanism related to retinoic acid-inducible gene-I-like receptors signaling pathway

Effects of andrographolide on NF-κB signaling pathway in human lung adenocarcinoma A549 cells

Activity of andrographolide and its derivatives against influenza virus in vivo and in vitro.

Andrographolide exerts anti-respiratory syncytial virus activity by up-regulating heme oxygenase-1 independent of interferon responses in human airway epithelial cells

Inhibitory Effects and Related Molecular Mechanisms of Huanglian-Ganjiang Combination Against H1N1 Influenza Virus

Study on the mechanism of andrographolide activation

Andrographolide Alleviates Oxidative Damage and Inhibits Apoptosis Induced by IHNV Infection via CTSK/BCL2/Cytc Axis

14-Deoxy-11,12-dehydroandrographolide exerts anti-influenza A virus activity and inhibits replication of H5N1 virus by restraining nuclear export of viral ribonucleoprotein complexes.

Andrographolide suppresses non-small-cell lung cancer progression through induction of autophagy and antitumor immune response

Andrographolide sulfonate downregulation of TLR3-TRIF and amelioration of airway inflammation caused by respiratory syncytial virus infection

Inhibitory effect of chlorogenic acid on the expression of the TLR7 signaling pathway in the presence of H1N1 infection in vitro

14-Deoxy-11,12-didehydroandrographolide inhibits apoptosis in influenza A(H5N1) virus-infected human lung epithelial cells via the caspase-9-dependent intrinsic apoptotic pathway which contributes to its antiviral activity

Andrographolide inhibits infectious bronchitis virus-induced apoptosis, pyroptosis, and inflammation

Anti-inflammatory effect and pharmacokinetics of dehydroandrographolide, an active component of Andrographis paniculata, on Poly(I:C)-induced acute lung injury

Andrographolide exerts a neuroprotective effect by regulating the LRP1-mediated PPARγ/NF-κB pathway

Effect of andrographolide on inflammation suppression of RAW264.7 cell induced by lipopolysaccharide

Immunomodulatory Activity of Andrographolide on Macrophage Activation and Specific Antibody Response

Andrographolide sulfonate reduces mortality in Enterovirus 71 infected mice by modulating immunity

Andrographolide ameliorates d-galactosamine/lipopolysaccharide-induced acute liver injury by activating Nrf2 signaling pathway

Antiviral Effect of Ginsenosides rk1 against Influenza a Virus Infection by Targeting the Hemagglutinin 1-Mediated Virus Attachment

Ifenprodil and Flavopiridol Identified by Genome-Wide RNAi Screening As Effective Drugs to Ameliorate Murine Acute Lung Injury after Influenza A H5N1 Virus Infection